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Protein ubiquitination impacts virtually every biochemical pathway in eukaryotic cells.
The fate of a ubiquitinated protein is largely dictated by the type of ubiquitin modification
with which it is decorated, including a large variety of polymeric chains. As a
result, there have been intense efforts over the last two decades to dissect the
molecular details underlying the synthesis of ubiquitin chains by ubiquitin-conjugating
(E2) enzymes and ubiquitin ligases (E3s). In this review, we highlight these advances.
We discuss the evidence in support of the alternative models of transferring one
ubiquitin at a time to a growing substrate-linked chain (sequential addition model)
versus transferring a pre-assembled ubiquitin chain (en bloc model) to a substrate.
Against this backdrop, we outline emerging principles of chain assembly: multisite
interactions, distinct mechanisms of chain initiation and elongation, optimal positioning
of ubiquitin molecules that are ultimately conjugated to each other, and substrate-
assisted catalysis. Understanding the enzymatic logic of ubiquitin chain assembly has
important biomedical implications, as the misregulation of many E2s and E3s and
associated perturbations in ubiquitin chain formation contribute to human disease.
The resurgent interest in bifunctional small molecules targeting pathogenic proteins to
specific E3s for polyubiquitination and subsequent degradation provides an additional
incentive to define the mechanisms responsible for efficient and specific chain synthesis
and harness them for therapeutic benefit.
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INTRODUCTION
The small protein ubiquitin is involved in nearly every cellular pathway through its covalent
attachment to target proteins (Hershko and Ciechanover, 1998; Oh et al., 2018). Ubiquitination
is notorious for triggering protein degradation through the 26S proteasome (Finley, 2009; Collins
and Goldberg, 2017; Yu and Matouschek, 2017). However, it can also alter protein structure and
function, induce changes in protein localization, and mediate the assembly or disassembly of
multi-protein complexes. What determines the fate of a ubiquitinated protein is the nature of
the modification (Komander and Rape, 2012; Swatek and Komander, 2016; Yau and Rape, 2016).
Ubiquitin molecules can be covalently attached to a target protein at one or several sites to afford a
(multi-) monoubiquitinated product and/or in the form of polyubiquitin chains. Owing to the eight
amino groups of ubiquitin (M1, K6, K11, K27, K29, K33, K48, and K63) along with the capacity
to form branched structures, the number of possible chain types is staggering; each one has the
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potential to govern the dynamics of a biochemical pathway in
a distinct manner (Figure 1). Due to the diverse functional
consequences, there has been intense interest in deciphering how
ubiquitin chains are assembled.
Over a decade ago, a thought-provoking review was published
describing the state of affairs regarding ubiquitin chain assembly
(Hochstrasser, 2006). At the time, several models had been
proposed, but the precise mechanisms by which ubiquitin chains
are generated on a substrate by the sequential activities of
E1 (ubiquitin-activating), E2 (ubiquitin-conjugating), and E3
enzymes (ubiquitin ligases) remained unclear. Since then, the
picture has become much less opaque: detailed kinetic studies
on several E2-E3 systems have supported a sequential addition
mechanism, in which ubiquitin molecules are added one at a
time, initially to the substrate and then to the distal end of
the growing chain (Pierce et al., 2009; Lu et al., 2015b; French
et al., 2017). In certain cases, chain initiation and elongation are
performed by two distinct E2 enzymes working in collaboration
with a single E3 (Rodrigo-Brenni and Morgan, 2007; Garnett
et al., 2009; Williamson et al., 2009; Wu K. et al., 2010; Wu T. et al.,
2010). In other instances, both steps are carried out by distinct
pairs of E2s and E3s (Scott et al., 2016; Dove et al., 2017a). With
some systems there is also evidence for an “en bloc” transfer of
pre-assembled ubiquitin chains to substrates (Wang and Pickart,
2005; Li et al., 2007; Ravid and Hochstrasser, 2007; Masuda et al.,
2012; Ronchi et al., 2013, 2017; Streich et al., 2013; Edwards et al.,
2014; Todaro et al., 2017).
In this review, we focus on the mechanistic intricacies of
ubiquitin chain formation. We start by providing a census of
the ubiquitination/deubiquitination machinery to underscore the
diversity of enzymes involved. We then revisit mechanisms of
chain assembly that have been put forward over the years,
providing detailed accounts in support of each one. Finally, we
outline the key factors underlying the efficiency, processivity, and
specificity with which E2s and E3s catalyze chain assembly.
CELLULAR MACHINERY
A massive collection of proteins encoded by ∼5% of the human
genome is responsible for sculpting the cellular ubiquitination
landscape (Clague et al., 2015; Figure 2). The apex of the system
is the E1 family of enzymes (Schulman and Wade Harper, 2009).
In humans, there are two E1s selective for ubiquitin: UBA1 and
UBA6. UBA1 is one of the most abundant protein in HeLa cells
(Kulak et al., 2014). UBA6—which is an order of magnitude lower
in abundance than UBA1—is unique in that it loads ubiquitin or
the ubiquitin-like modifier FAT10 specifically onto the E2 UBE2Z
(USE1), whereas UBA1 transfers ubiquitin to a wide array of E2s
(Chiu et al., 2007; Jin et al., 2007; Pelzer et al., 2007; Aichem
et al., 2010). The human genome encodes ∼40 E2s dedicated to
ubiquitin conjugation (Michelle et al., 2009; Yates et al., 2017).
Several of them are limited to monoubiquitination; others act
as “chain extenders” by modifying ubiquitin itself. A subset of
E2s synthesize a single linkage type between ubiquitin molecules,
while others are promiscuous (Ye and Rape, 2009; Wenzel et al.,
2015; Stewart et al., 2016).
By selecting substrates and modifying them with ubiquitin
chains, E3s play a pivotal role in ubiquitin signaling. Considering
most proteins in the cell are subject to ubiquitination, the
substrate repertoire of E3s is immense. To meet this demand,
the human genome encodes over 600 E3s (Li et al., 2008), which
fall into three mechanistic classes: the RING (really interesting
new gene)/U-box, HECT (homologous to E6AP C-terminus),
and RBR (RING-between-RING) ligases (Buetow and Huang,
2016). The RING/U-box ligases are the largest of these classes and
catalyze the direct transfer of ubiquitin from a thioester-linked
E2-ubiquitin conjugate (E2∼ubiquitin) to a substrate (Deshaies
and Joazeiro, 2009; Metzger et al., 2014). The 28 human HECT
(Huibregtse et al., 1995; Lorenz, 2018; Weber et al., 2019) and 14
RBR (Marín et al., 2004; Smit and Sixma, 2014; Dove and Klevit,
2017; Walden and Rittinger, 2018) ligases proceed through a two-
step mechanism, in which ubiquitin is first transferred from an
E2 to the active site cysteine of the E3 to afford an E3∼ubiquitin
thioester-linked intermediate and then delivered to a substrate
(Huang et al., 1999; Wenzel et al., 2011).
The ∼100 human deubiquitinases (DUBs) antagonize the
activity of E3s by severing the isopeptide linkage between
ubiquitin and a substrate or disassembling ubiquitin chains
(Clague et al., 2013, 2019; Mevissen and Komander, 2017).
DUBs are sub-categorized into seven families: the ubiquitin
C-terminal hydrolases (UCHs), ubiquitin specific proteases
(USPs), Machado-Josephins (MJDs), ovarian tumor proteases
(OTUs), JAB1/MPN domain-associated metalloisopeptidases
(JAMM/MPN+), the novel MIU-containing DUB family MINDY
(Abdul Rehman et al., 2016), and the zinc finger with UFM1-
specific peptidase domain-containing ZUFSP family (Haahr
et al., 2018; Hermanns et al., 2018; Hewings et al., 2018; Kwasna
et al., 2018). All but the JAMM/MPN+ metalloproteases catalyze
bond cleavage using an active-site cysteine residue reminiscent of
canonical cysteine proteases such as papain. Proteins containing
ubiquitin-binding domains (UBDs) typically act as effectors
transmitting the recognition of different ubiquitin modifications
into a biological response (Husnjak and Dikic, 2012).
WHAT ARE THE DIFFERENT
MECHANISMS OF CHAIN ASSEMBLY?
Several models for chain assembly have been entertained over
the years (Hochstrasser, 2006). While these models involve
different oligomerization states of E2s and E3s, they all follow
either of two basic mechanisms—sequential addition and en bloc
transfer—which differ in the directionality of chain growth and
location of the growing chain. Sequential addition—presumably
the predominant mechanism—requires the transfer of individual
ubiquitin molecules to a substrate. By contrast, the en bloc
mechanism involves transferring chains that have been pre-
formed on the active-site cysteine of an E2 or HECT/RBR
E3 to a substrate.
Sequential Addition
According to the sequential addition model, each ubiquitinated
substrate species acts as a substrate for the formation of
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FIGURE 1 | The diversity of ubiquitin chains enables highly nuanced mechanisms of regulation. (A) Structure of ubiquitin (PDB: 1UBQ) showing the seven lysine side
chains (K6, K11, K27, K29, K33, K48, and K63) and the N-terminus along with the I36 and I44-centered hydrophobic patches, highlighted in green (L8, I36, L70,
and L73) and blue (L8, I44, H68, and V70), respectively. (B) Types of ubiquitin chains that can be produced. Homotypic chains are assembled using the same amino
group of ubiquitin for each linkage, whereas heterotypic chains contain a mixture of linkages. Branched chains are a form of heterotypic chain, in which at least one
ubiquitin molecule is modified by two or more ubiquitin molecules. (C) The relative orientation of the I36 and I44-centered hydrophobic patches controls how different
chain types are recognized by effector proteins and DUBs.
FIGURE 2 | Cellular machinery involved in ubiquitination. protein ubiquitination is driven by E1 (ubiquitin-activating), E2 (ubiquitin-conjugating), and E3
(ubiquitin-ligating) enzymes. Three distinct classes of ubiquitin ligases—RING/U-box (top), HECT (middle), and RBR (bottom)—utilize different structural mechanisms
for mediating the final transfer of ubiquitin onto substrates.
successively longer substrate-linked chain (Figure 3A). Thus,
new ubiquitinated species appear in a sequential manner with
a lag phase proportional to chain length. The challenge in
providing evidence for this mechanism lies in the necessity
to detect individual reaction products/intermediates on fast
timescales of milliseconds to seconds.
This was first accomplished using the yeast Skp-cullin-F-
box protein complex SCFCdc4 (human homolog of Cdc4 is
FBXW7) as a model system (Pierce et al., 2009). SCFCdc4 is
the founding member (Feldman et al., 1997; Skowyra et al.,
1997) of the largest family of E3s—the cullin-RING ligases
(CRLs) (Petroski and Deshaies, 2005a)—which account for∼20%
of all proteasome-dependent degradation (Soucy et al., 2009).
It cooperates with the K48 linkage-specific E2 Cdc34 (human
enzyme is referred to as UBE2R1) (Petroski and Deshaies, 2005b;
Gazdoiu et al., 2007; Ziemba et al., 2013; Choi et al., 2014;
Chong et al., 2014; Hill et al., 2016). Together, SCFCdc4 and
Cdc34 catalyze substrate polyubiquitination within seconds.
Using single-encounter assays, it was shown that most encounters
of Cdc34-SCFCdc4 with a substrate are futile (Pierce et al., 2009);
however, the vast majority of modified substrate molecules carry
chains with ≥4 ubiquitin moieties (Saha and Deshaies, 2008). To
determine whether substrate ubiquitination by Cdc34-SCFCdc4
occurs en bloc or sequentially, the distribution of ubiquitin
chains conjugated to Cdc34 was measured by intact mass
spectrometry (Pierce et al., 2009); the logic being that the product
distribution should reflect the population of Cdc34∼ubiquitin
conjugates if pre-formed chains were transferred from the
E2 to the substrate en bloc. However, Cdc34 conjugates
bearing more than one ubiquitin could not be detected in
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FIGURE 3 | Mechanisms of Ubiquitin Chain Assembly. (A) The sequential addition model implies the transfer of ubiquitin molecules one at a time. The fractional
conversion profile of product formation will show a lag phase proportional to chain length for each new ubiquitinated species formed. (B) In the en bloc model,
pre-assembled ubiquitin chains anchored to the active site of an E2 or E3 are transferred to a substrate. If the pre-assembly of chains is much faster than the transfer
of chains to the substrate, a lag phase proportional to chain length should not be observed in the fractional conversion profile. (C) Basic step of an en bloc transfer
mechanism: The ubiquitin conjugated to the active site of an E2 or HECT/RBR E3 provides an acceptor lysine residue to attack the C-terminus of another
thioester-linked ubiquitin tethered to another E2 or E3.
this set-up, thus offering indirect support for a sequential
addition mechanism.
The most compelling evidence for the sequential addition
mechanism comes from millisecond kinetic measurements
(Pierce et al., 2009). Such time resolution is sufficient to detect
whether chains are formed sequentially or contemporaneously.
In the case of Cdc34-SCFCdc4 and UBE2R1-SCFβ—TrCP, each
new ubiquitinated species was found to occur sequentially
with non-concurrent lag phases; in other words, each reaction
intermediate acts as a substrate during each round of chain
elongation. Kinetic analyses revealed that transferring the first
ubiquitin (a step represented by kUb1) is the slowest step during
ubiquitin chain assembly, which is why most enzyme-substrate
encounters are unproductive. Once the first ubiquitin is in place,
the rates of sequential ubiquitin additions (kUb−n) are markedly
faster than substrate dissociation (koff), allowing for multiple
transfer events to occur before the enzyme-substrate complex
dissociates. As a result, polyubiquitination is processive. Just as
the probability of acquiring a chain depends on the ratio of
kUb1 to koff, the length of a chain is determined by the rates of
the additional ubiquitin transfer (kUb−n) and koff. Reductions in
kUb−n manifest with increasing chain length, as the distal end of
the growing chain samples more conformational space.
With certain E3s, e.g., the 1.3 MDa CRL APC/C, the
conformational space occupied by the growing chain can be
restricted by subunits harboring ubiquitin-binding domains
(Brown et al., 2014; Kelly et al., 2014), resulting in a
decrease in koff and an increase in kUb−n. As described in
more detail below, single-molecule measurements combined
with detailed structural and biochemical studies have shown
that the APC/C assembles ubiquitin chains through a feed-
forward mechanism termed processive affinity amplification
(PAA) (Lu et al., 2015b). The basic premise is that substrates
carrying more ubiquitin molecules/longer ubiquitin chains are
preferentially ubiquitinated compared to substrates carrying
fewer ubiquitin molecules/shorter chains. In essence, each
ubiquitin molecule added to the substrate enhances the affinity
of the modified substrate for the APC/C, thus rendering chain
formation processive.
A consequence of the sequential addition mechanism is
that the processivity of ubiquitin linkage formation can dictate
chain length and, thus, the fate of the substrate protein. In
the case of the Cdc34/UBE2R1-SCF complexes, the rate-limiting
transfer of the first ubiquitin affords two distinct populations of
substrate–unmodified and extensively polyubiquitinated (Pierce
et al., 2009). How fast a substrate is decorated with the first
ubiquitin will thus largely determine how fast it is degraded
by the proteasome, assuming ubiquitination is rate-limiting
during degradation.
The situation is different with the HECT ligase WWP1.
Time course data shows that WWP1 catalyzes K63-linked
ubiquitin chains on its substrates in a sequential manner
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with a lag phase proportional to chain length (French
et al., 2017). Once the chain reaches ∼4 subunits in length,
WWP1 switches to building chains linked through K11 and
K48, presumably due to topological constraints on the distal
ubiquitin within the substrate-tethered K63 chain. Thus, even
if the multidirectional phase is slow, the substrate can be
modified with short K63 chains to possibly direct proteasome-
independent events. In contrast, branched chains, as formed
during the second phase of the reaction promote proteasomal
degradation of the modified substrate (Meyer and Rape,
2014; Grice et al., 2015; Liu et al., 2017; Yau et al., 2017;
Ohtake et al., 2018).
Sequential addition also lends itself to fine-tuning of the
polyubiquitinated protein by DUBs (Zhang et al., 2013): consider
two substrates with slightly different affinities for an E3. Both
acquire ubiquitin moieties at roughly the same rate, but one is
released faster than the other. Every time dissociation occurs,
the growing ubiquitin chain may be exposed to a DUB, thus
running the risk of disassembly. Indeed, incorporating DUB
activity into a kinetic model for sequential addition reveals
that a two-fold increase in koff results in over an eight-
fold decrease in chain formation. In other words, modest
differences in E3-substrate affinity afford significant differences
in the extent to which substrates are modified with ubiquitin
in a single encounter with the E3. In turn, this affects
the efficiency of their proteasome-mediated degradation or
alternative downstream responses.
En Bloc Transfer
In addition to transferring individual ubiquitin molecules to a
growing substrate-linked chain, there is evidence that certain
systems can pre-form chains on the active site cysteine of an
E2 or E3 before transfer to a substrate (Figure 3B). From
the perspective of maximizing the efficiency with which a
substrate is polyubiquitinated, such en bloc transfer is ideal:
unlike the sequential addition mechanism, an E3-substrate
complex does not have to be long-lived for the substrate to
receive a chain of sufficient length for downstream signaling
events. Instead, the population of E2- or E3-tethered chains
dictates how a substrate is modified. On the flip side,
en bloc transfer requires the mechanisms of chain pre-
formation on the respective enzyme to be much faster than
substrate transfer.
En bloc transfer was first proposed based on biochemical
studies with the K48-specific HECT E3 UBE3A (E6AP) (Wang
et al., 2006). As with all HECT E3s, ubiquitin is transferred
from an E2 (UBE2L3) to the active-site cysteine of UBE3A
to form a thioester-linked conjugate. En bloc assembly of
chains by UBE3A then implies that the ubiquitin conjugated to
the active site of UBE3A provides the acceptor lysine residue
(K48) to attack the C-terminus of another thioester-linked
ubiquitin tethered to either a UBE3A subunit (in the context
of an UBE3A oligomer) or an associated E2 (Figure 3C).
Consistent with this notion, mixing UBE3A∼ubiquitin with
a ubiquitin molecule that cannot be activated as a thioester
precludes the formation of di-ubiquitin. However, di-ubiquitin
can be generated upon reacting UBE3A∼ubiquitin with an
E2∼K0-ubiquitin conjugate (ubiquitin variant lacking lysine
residues). When a substrate is added to the picture, e.g.,
the ubiquitin-binding protein HHR23A, the K48-linked di-
ubiquitin is transferred to HHR23A, suggesting en bloc
transfer is chemically feasible. However, UBE3A-bound di-
(or poly)ubiquitin has not been detected directly. Recently,
steady-state kinetic analyses have led to a model in which
E2∼ubiquitin conjugates bind two functionally distinct sites
on trimers of the catalytic domain of UBE3A (Ronchi et al.,
2013, 2014, 2017) and NEDD4 subfamily members (Todaro
et al., 2017, 2018), respectively, to build active site-anchored
ubiquitin chains for en bloc transfer. Yet, as mentioned
above, the NEDD4-type WWP1 builds chains sequentially
(French et al., 2017).
Time course analyses suggested that en bloc transfer also
applies to certain E2/RING E3 systems. The human E2 UBE2G2
(Fang et al., 2001; Chen et al., 2006) and its yeast ortholog
Ubc7 (Biederer et al., 1996; Hiller et al., 1996; Bays et al.,
2001; Deak and Wolf, 2001) are associated with the ER
membrane and responsible for K48-linked ubiquitin chain
formation on misfolded polypeptides exported from the ER
lumen during ERAD. In the presence of the ER-resident
E3 GP78, UBE2G2 was found to catalyze the assembly of
ubiquitin chains on its active-site cysteine (Li et al., 2007).
The propensity for GP78 to oligomerize drives this preassembly
process, as the formation of UBE2G2-GP78 hetero-oligomers
brings the active sites of multiple UBE2G2 molecules into
close proximity (Li et al., 2009; Liu et al., 2014). With
UBE2G2∼ubiquitin conjugates juxtaposed, K48 of one ubiquitin
is thought to attack the C-terminus of the neighboring thioester-
linked one.
Besides UBE2G2, UBE2K, and Ubc7, have also been found
conjugated to ubiquitin chains through a thioester linkage
(Haldeman et al., 1997; Ravid and Hochstrasser, 2007; Bazirgan
and Hampton, 2008). The rate at which chains are formed on
the active-site cysteine of UBE2G2 is slightly faster than the
rate of transfer to a substrate lysine residue, suggesting en bloc
transfer is kinetically feasible during the polyubiquitination of a
substrate (Li et al., 2007). That said, fast kinetic measurements
of product distributions would be helpful to validate this
mechanism and confirm that substrate-anchored ubiquitin
chains indeed reflect the distribution of chains attached to the
active site of UBE2G2.
WHAT ARE THE KEY MOLECULAR
FEATURES REQUIRED FOR CHAIN
ASSEMBLY?
Ubiquitin chain formation requires a molecular juggling
act (Lorenz et al., 2013). In the context of the sequential
addition model, an E3 has to engage a substrate and a
thioester-linked E2-donor ubiquitin complex, transfer
ubiquitin to a primary amino group of the substrate, and
then switch to one of eight primary amino groups of an
acceptor ubiquitin to promote chain elongation. All of these
events must occur while the substrate remains bound to
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FIGURE 4 | Conformational Flexibility of the Donor and Acceptor Ubiquitin Are Restrained During Chain Assembly. (A) The donor ubiquitin covalently tethered to the
active-site cysteine of an E2 can adopt multiple conformations, referred to as “open” and “closed.” The closed conformation is important during catalysis with RING
E3 enzymes. The E1/E3 binding site and the backside of an E2 are also highlighted on the structure of UBE2D2 (PDB: 5ULF). (B) As a chain increases in length, it
can occupy more conformational space (top). Low-affinity ubiquitin-binding domains (shown in purple) can assist in limiting the conformational space of the chain
and positioning the acceptor ubiquitin for the nucleophilic attack on the E2∼donor ubiquitin conjugate.
the E3 to minimize the number of encounters required
to build a chain.
Multisite E2-E3 Interactions During
Chain Formation
Structural studies have shown that E3s interact with the same
surface of E2s that is recognized by E1 enzymes (Figure 4A;
Eletr et al., 2005; Huang et al., 2005; Kamadurai et al., 2009;
Lechtenberg et al., 2016; Dove et al., 2017b; Yuan et al.,
2017; Condos et al., 2018; Sauvé et al., 2018). Such mutually
exclusive binding places a major constraint on the mechanism
of polyubiquitination because the spent E2 must dissociate from
the E3 after ubiquitin transfer to allow for ubiquitin reloading.
Assuming the association between E3 and an E2∼ubiquitin
conjugate is governed by short-range interactions (e.g., van der
Waals), and thus diffusion-controlled, the on-rate would be≤106
M−1s−1 (Alsallaq and Zhou, 2008; Schreiber et al., 2009). With an
intracellular concentration of E2∼ubiquitin conjugate estimated
to be around 1 µM (Kleiger et al., 2009a), the complex would
form at a rate of 1 s−1. If the affinity is ∼10 µM, the off-rate
would be 10 s−1. For six rounds of conjugation, the assembly and
disassembly of an E2-E3 complex would thus consume ∼6 s of
the entire process. At first glance, these numbers seem reasonable,
considering kinetic studies have shown that a substrate can
acquire up to six ubiquitin molecules in ∼10 s, as catalyzed by
the Cdc34-SCF complex (Saha and Deshaies, 2008). However,
Cdc34∼ubiquitin binds tightly to SCF with a Kd in the low
nanomolar range (Saha and Deshaies, 2008). The overall rate of
cyclical binding and release would thus not be conducive to the
processive assembly of a ubiquitin chain.
A balance between affinity and processivity is achieved
through bipartite interactions. Cdc34 not only engages SCF
through the Rbx1 RING subunit, but also possesses an
acidic C-terminal tail that interacts with a conserved basic
cleft on the cullin subunit (Kleiger et al., 2009b). These
electrostatic interactions govern the initial, rapid recognition,
while interactions between Rbx1 and Cdc34 position and
activate the ubiquitin-loaded E2 for transferring ubiquitin to
the substrate. With electrostatic forces driving the interaction
between Cdc34 and SCF, the on-rate is two orders of magnitude
faster than the diffusion-controlled limit. The off-rate thus does
not have to be slow in order to achieve nanomolar affinity.
Since the off-rate is >30 s−1, binding and release can occur
before substrate dissociation. That electrostatic forces govern
the interactions between Cdc34 and the SCF has an additional
advantage: due to their weaker dependence on distance (1/r)
compared to van-der-Waals interactions (1/r6) allows the spent
E2 to remain in close proximity to the E3 while it is recharged
with ubiquitin by an E1. The importance of electrostatic forces in
Cdc34-CRL interactions is underscored by the fact that the basic
cleft is conserved across the cullin family.
Other multi-component E2-CRL assemblies have also evolved
multisite binding mechanisms for processive polyubiquitination.
For example, the human APC/C cooperates with two E2s,
UBE2C and UBE2S, to catalyze polyubiquitination of key
cell cycle regulators, thereby regulating cellular progression
through mitosis—a process that has recently been reconstructed,
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primarily due to the power of cryo-electron microscopy (Alfieri
et al., 2017; Watson et al., 2019). UBE2C initiates chain synthesis,
while UBE2S catalyzes chain elongation in a K11-linkage specific
manner (Jin et al., 2008; Garnett et al., 2009; Williamson et al.,
2009; Wu T. et al., 2010; Wickliffe et al., 2011). The rate ot
substrate degradation is determined by the efficiency of chain
initiation as well as the nature and extent of polyubiquitination
(Rape et al., 2006; Williamson et al., 2011; Lu et al., 2015a).
Processivity in ubiquitination, as achieved through the PAA
mechanism discussed above (Lu et al., 2015b), ensures efficient
substrate degradation and involves distinct multisite interactions
of the APC/C with UBE2C and UBE2S.
During the priming reaction, the APC/C engages UBE2C in
a canonical mode through its RING domain (APC11) and via
the winged-helix B (WHB) domain of APC2 (Brown et al., 2014,
2015, 2016). The WHB domain binds the “backside” of UBE2C,
which is located on the opposite side of the donor ubiquitin
binding site and provides an important allosteric site in a number
of E2s (Miura et al., 2002; Brzovic et al., 2006; Bocik et al.,
2011; Hibbert et al., 2011; Page et al., 2012; Ranaweera and
Yang, 2013). Investigations into another RING E3, RNF38, and
the E2 UBE2D2 (Buetow et al., 2015) have shown that backside
binding of ubiquitin to UBE2D2 limits the flexibility of the RING
domain binding site and stabilizes the catalytically active closed
conformation of UBE2D2∼ubiquitin (Figure 4A; Saha et al.,
2011; Wickliffe et al., 2011; Dou et al., 2012, 2013; Plechanovová
et al., 2012; Pruneda et al., 2012; Soss et al., 2013; Branigan et al.,
2015; Dove et al., 2017b). The net result is a dramatic increase
in catalytic efficiency. Based on these data, the WHB domain
of APC2 might not only limit the search radius of the dynamic
UBE2C-APC11 assembly to specific lysines of a substrate (Brown
et al., 2015), but also potentiate ubiquitin transfer.
In other systems, backside interactions enable rapid cycling
between E2 binding and release. For example, the G2BR domain
of GP78 was found to bind to the backside of UBE2G2 with
low nanomolar affinity (Das et al., 2009; Li et al., 2009). This
interaction induces conformational changes in UBE2G2 that
result in an increase in the affinity for the RING domain of
GP78 by ∼50-fold. Assuming the binding energies are additive
(Jencks, 1981), an overall Kd in the picomolar range would be
expected. Such tight binding could adversely affect E2 exchange
from the E3 and ultimately processivity; however, the measured
Kd turns out to be∼103 times higher than calculated. As revealed
through biophysical studies, UBE2G2 is released from GP78
by an allosteric feedback mechanism in which binding of the
RING domain to UBE2G2 reduces the number of electrostatic
interactions between UBE2G2 and G2BR (Das et al., 2013). The
kinetics in this system are such that the off-rate of UBE2G2 from
G2BR is much faster than the rate of ubiquitin transfer. Since the
E1 cannot charge the G2BR-bound form of UBE2G2 as efficiently
as free UBE2G2, complete release of the E2 is likely important for
consecutive cycles of ubiquitination.
Chain elongation on APC/C substrates involves a unique
set of bipartite interactions between the APC/C and UBE2S.
UBE2S is primarily recruited to APC/C through its 66-residue
C-terminal peptide (CTP) extension (Meyer and Rape, 2014;
Brown et al., 2016), which nestles into a complementary acidic
and hydrophobic groove at the interface between the APC2 and
APC4 subunits. The catalytic UBC domain of UBE2S is held
in place by the cullin APC2, not the APC11 RING domain, to
promote chain elongation (Brown et al., 2016). The APC11 RING
domain instead serves a non-canonical role during this process
by tracking the distal acceptor ubiquitin molecule of the growing
ubiquitin chain (Kelly et al., 2014; Brown et al., 2016).
Distinct Enzymes for Priming and
Extension
The distinct reactions of monoubiquitination/priming and
polyubiquitination/elongation that are catalyzed by E3s present
significant challenges. During the priming phase, ubiquitin is
directly attached to a substrate protein. For this process to be
site-specific, spatial restrictions (Kamadurai et al., 2013) or active
participation from the substrate (Jin et al., 2008; Mattiroli et al.,
2012, 2014) are required. In most cases monoubiquitination
occurs at multiple lysines with little dependence on sequence
context (Petroski and Deshaies, 2003; Tang et al., 2007; Fischer
et al., 2011). By contrast, chain elongation often occurs
with specificity for the amino group of ubiquitin that is
modified (Wenzel and Klevit, 2012). To achieve specificity
during sequential addition, an E3 needs to repeatedly position
the distal acceptor ubiquitin molecule in a growing chain
with high precision.
E3s have evolved different mechanisms to meet this demand.
The APC/C, for example, uses two different E2s for priming and
extension (Rodrigo-Brenni and Morgan, 2007). The recognition
of a substrate’s degron motif (a KEN- or D-box) by the APC/C
co-factors CDH1 or CDC20, respectively, along with the APC10
subunit (Fang et al., 1998; Pfleger and Kirschner, 2000) places the
substrate in close proximity to the UBE2C∼ubiquitin conjugate
(Brown et al., 2016). Confined to the same space within the
central cavity of APC/C, UBE2C can readily modify the substrate
with individual ubiquitin molecules and/or short K11, K48, and
K63 chains (Kirkpatrick et al., 2006). Thereafter, the APC/C
subsequently juxtaposes UBE2S with the acceptor ubiquitin
(Brown et al., 2016), thus providing an optimal geometry
for processive and specific chain elongation using K11 of
ubiquitin (Wickliffe et al., 2011). What is particularly interesting
about the different catalytic architectures of the APC/C is
the potential for differential regulation by macromolecular
factors and posttranslational modifications, e.g., phosphorylation
(Reimann et al., 2001; Craney et al., 2016; Qiao et al., 2016).
Similar to the APC/C, SCF ligases are known to collaborate
with several E2s. In this case, UBE2D2/D3 transfers the first
ubiquitin, while UBE2R1 catalyzes K48-linked chain elongation
(Wu K. et al., 2010). In a surprising turn of events, SCFs were
also found to team up with another E3 ligase to carry out the
distinct steps of priming and extension (Scott et al., 2016; Dove
et al., 2017a). Using genome and proteome-wide screens, the
RBR E3 HHARI and its Caenorhabditis elegans ortholog ARI-
1 were shown to associate with the NEDD8-modified/activated
forms of CRLs. Like many RBRs, HHARI/ARI-1 exists in an
autoinhibited state in which its Ariadne domain interacts with
the RING2 domain (Duda et al., 2013), thereby blocking the
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catalytic cysteine and preventing transfer of ubiquitin from the
cognate E2 UBE2L3/UBC-18. Autoinhibition is relieved upon
binding of NEDD8-modified CRLs. Once charged with ubiquitin,
HHARI catalyzes the monoubiquitination of CRL substrates.
With the substrate primed, UBE2R1 then works with the CRL to
form a K48-linked chain. While this cooperative mode of action
of HHARI and NEDD8-modified CRLs is conceptually unique,
there are other examples of ubiquitin ligases that regulate each
other through macromolecular interfaces (Kühnle et al., 2011).
When two E3s act independently but sequentially to prime
and extend, the ubiquitin-dependent outcome can change
dramatically. In response to replication fork collapse, for
example, the DNA polymerase processivity factor PCNA
(proliferating cell nuclear antigen) is monoubiquitinated by Rad6
(an E2) and Rad18 (an E3) to promote an error-prone damage
tolerance process known as translesion DNA synthesis (Hoege
et al., 2002; Stelter and Ulrich, 2003). Switching to an error-
free, lesion bypass process requires collaboration between the
E3 Rad5 and E2 Ubc13/Mms2 to build K63-linked chains, with
the monoubiquitinated product of Rad6-Rad16 serving as the
substrate for Ubc13/Mms2-Rad5 (Hoege et al., 2002; Parker
and Ulrich, 2009). The HECT E3s HUWE1 and UBR5 also
use ubiquitinated substrates to seed chain extension. HUWE1
has been shown to recognize substrates primed with K63-linked
chains by another E3, e.g., TRAF6, and extend a K48-linked
chain from a branch point (Ohtake et al., 2016), transforming the
ubiquitin-dependent signal from non-degradative to degradative.
Likewise, UBR5 installs K48 branch points on preexisting chains
built by other E3s, e.g., ITCH and UBR4, and continues to extend
the chains with K48 linkages for the purpose of creating a more
potent proteasome-targeting signal (Yau et al., 2017; Ohtake et al.,
2018). Whether HUWE1 and UBR5 prefer an internal ubiquitin
subunit within a chain, similar to the yeast branching enzyme
Ufd2 (Liu et al., 2017), or any subunit can serve as the starting
point for chain extension remains unclear.
Orienting the Acceptor Ubiquitin
While the orientation of the donor ubiquitin toward the E2
or E3 is an important part of preparing the active site for the
nucleophilic attack of the acceptor, both chemically and sterically
(Figure 4A; Saha et al., 2011; Wickliffe et al., 2011; Dou et al.,
2012, 2013; Plechanovová et al., 2012; Pruneda et al., 2012; Soss
et al., 2013; Branigan et al., 2015; Lorenz et al., 2016; Dove et al.,
2017b), the acceptor ubiquitin must also be positioned properly
to maximize the efficiency and processivity of chain formation
(Figure 4B; Wright et al., 2016). One can think about this
problem from an entropic perspective: as the length increases, a
chain can occupy more conformational space. To avoid a large
entropic penalty, E2s and E3s must limit the conformational
freedom of a growing chain by placing the acceptor ubiquitin
in close proximity to the donor. Importantly, how an acceptor
ubiquitin is oriented toward the donor also determines the
specificity of linkage formation.
The first clue for how an acceptor ubiquitin is positioned
for the formation of a specific linkage came from structural
studies of the K63-specific yeast E2 Ubc13 (human enzyme;
UBE2N) and its co-factor, the ubiquitin E2 variant (UEV)
Mms2 (UBE2V2). A crystal structure of the Mms2-Ubc13-donor
ubiquitin conjugate showed the donor ubiquitin of one complex
binding to the Mms2 molecule of a neighboring Mms2-Ubc13
complex (Eddins et al., 2006). The resulting contacts between
Mms2 and ubiquitin position K63 near the active site of the
adjacent Ubc13, mimicking an acceptor ubiquitin. This structure
thus illustrated how an accessory protein can assist in limiting the
orientation of the acceptor ubiquitin toward the catalytic center
of an E2 and allow for specificity in acceptor lysine selection.
More recently, the crystal structures of a UBE2V2/UBE2N-donor
ubiquitin complex bound to the dimeric RING domain of RNF4
revealed that the RING domain tethers the donor ubiquitin in
an activated closed conformation toward the E2, thus stimulating
catalysis (Branigan et al., 2015); this mechanism has emerged
as a canonical principle of RING-mediated catalysis in several
E2/E2 systems (Dou et al., 2012; Plechanovová et al., 2012;
Pruneda et al., 2012).
By contrast, the APC/C relies on a non-canonical interaction
between its RING domain (APC11) and the acceptor ubiquitin: a
hydrophobic patch of APC11 engages ubiquitin through residues
surrounding K48 along with the C-terminus, thus blocking K48
from serving as an acceptor lysine (Brown et al., 2016), and
allowing K11 to be presented to the activated C-terminus of
the UBE2S-linked donor. Kinetic studies suggest this mechanism
accounts for a 40-fold decrease in Km and an overall 175-fold
increase in catalytic efficiency (Brown et al., 2016).
Interestingly, UBE2S can achieve K11 linkage specificity in
the absence of the APC/C (Bremm et al., 2010; Matsumoto
et al., 2010; Wickliffe et al., 2011). The key to this inherent
specificity lies in the activation of the acceptor lysine, K11,
by an adjacent acidic side chain, E34, of ubiquitin, which
promotes the nucleophilic attack of K11 through facilitating its
deprotonation (Wickliffe et al., 2011). This mechanism, known
as substrate-assisted catalysis, triggers isopeptide bond formation
specifically when K11 is presented to the UBE2S active site, while
other acceptor orientations are catalytically disfavored. Notably,
ubiquitin was also found to contribute to catalysis in HECT
E3s (Ries et al., 2019) and DUBs (Keusekotten et al., 2013;
Mevissen et al., 2016), suggesting substrate-assisted catalysis is
a conserved theme in different classes of ubiquitinating and
deubiquitinating enzymes.
Principles of acceptor ubiquitin recognition have also started
to emerge outside of the RING E3 family. For instance,
structural studies of the RBR-type linear ubiquitin chain assembly
complex (LUBAC) has revealed dedicated interaction sites for
the acceptor ubiquitin. LUBAC generates M1-linked chains to
regulate innate immunity and inflammation through the NF-
κB pathway (Kirisako et al., 2006; Ikeda et al., 2011; Tokunaga
et al., 2011) and is composed of two RBR E3 subunits: HOIP
and HOIL-1L; however, only one of the RBRs (HOIP), contains
the catalytic activity necessary for generating M1-linked chains
(Smit et al., 2012; Stieglitz et al., 2013). The structure of a
minimal HOIP–ubiquitin transfer complex shows the α-amino
group of the acceptor residue, M1, poised for the nucleophilic
attack on the donor ubiquitin (Lechtenberg et al., 2016). In this
complex, the RING2-domain together with the “linear ubiquitin
chain determining region” (LDD) of HOIP create a platform
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that ensures the α-amino group of the acceptor is positioned
in proximity to the active site. Deprotonation of this amino
group, as required for its nucleophilic function, is promoted by
a particular histidine residue of HOIP.
In HECT E3s, the structural basis of acceptor ubiquitin
recognition has remained elusive. However, a particular region,
known as the “exosite,” in the N-lobe of the catalytic HECT
domain, was shown to engage a regulatory ubiquitin molecule,
thus promoting chain elongation but not initiation (Ogunjimi
et al., 2010; Kim et al., 2011; Maspero et al., 2011, 2013; Zhang
et al., 2016; French et al., 2017; Ries et al., 2019). It has thus
been hypothesized that the exosite contributes indirectly to
stabilizing the acceptor ubiquitin in proximity to the active site by
interacting with flanking ubiquitin moieties within the growing
chain (Fajner et al., 2017).
Finally, Cue1, a receptor and activator of the yeast E2 Ubc7
that is crucial for ERAD (Biederer et al., 1997), provides an
example of how an accessory protein can impact the acceptor
ubiquitin to promote ubiquitin linkage formation. Cue1 harbors
an N-terminal ubiquitin-binding CUE domain and a C-terminal
Ubc7 binding region (U7BR), which likely activates Ubc7 in
a manner analogous to the G2BR domain of GP78 (Bazirgan
and Hampton, 2008; Kostova et al., 2009; Metzger et al., 2013).
NMR studies and in vitro ubiquitination reactions revealed that
the CUE domain accelerates chain formation by binding to
the penultimate ubiquitin molecule in a growing chain, thereby
assisting U7BR in orienting the distal acceptor moiety toward
the active site of Ubc7 formation (Bagola et al., 2013; von
Delbrück et al., 2016). Although the overall impact of Cue1 on
the kinetics of chain formation is modest in vitro, the mechanistic
implications are rather intriguing. Kinetic measurements show
that the off-rate of the CUE domain-ubiquitin complex is fast
compared to the rate of isopeptide bond formation. Thus, the
CUE domain can “hop” along a chain without affecting the
overall rate of chain formation until it finds the ubiquitin moiety
adjacent to the acceptor. E3s capable of elongating existing
ubiquitin chains by installing branch points could use similar
enzymatic logic (Koegl et al., 1999; Metzger and Weissman,
2010; Ohtake et al., 2016, Ohtake et al., 2018; Liu et al., 2017;
Yau et al., 2017).
OUTLOOK
The progress made over the last decade in understanding how
ubiquitin chains are assembled is astonishing. Most notably,
detailed kinetic analyses have illustrated the complexities of the
sequential addition mechanism in the context of CRLs. Moreover,
synergistic advances in structural biology, genomic engineering,
quantitative mass spectrometry, and chemical biology have
helped elucidate central operating principles underlying the
activities of E2s and E3s, including multi-site interactions, the
cooperative interplay of distinct enzymes for chain initiation and
elongation, the precise positioning of the donor and acceptor
ubiquitin, and substrate-assisted catalysis. While these principles
have been found to recur in various model systems studied,
it is important to realize that each class of E3s appears to
implement these principles by distinct structural mechanisms,
thus contributing to the enormous versatility and specificity of
ubiquitin signaling.
Despite considerable advances in understanding the
mechanistic principles of ubiquitin chain formation,
reconstituting and structurally visualizing the trajectory of
the functional enzyme-substrate assemblies has been challenging.
This is due, for the most part, to the weak and dynamic nature of
the underlying macromolecular interactions, which typically fall
into the hig micromolar to millimolar affinity range in vitro. To
overcome this challenge, crosslinking approaches have emerged
as indispensable tools, opening exciting avenues to capture
specific complexes for structural analyses (Witting et al., 2017).
The immense potential of ubiquitin ligases as therapeutic
targets has been illustrated by the clinical efficacy of thalidomide
and its derivatives in the treatment of hematological malignancies
(Lindner and Krönke, 2016). However, progress toward
rationally manipulating E3s has been impeded largely by our
insufficient understanding of their conformational dynamics,
macromolecular interactions, and functional integration
into cellular pathways (Huang and Dixit, 2016; Chen et al.,
2018). Over the next few years, it will be exciting to see how
the mechanisms of critical, yet uncharacterized E3s unfold,
especially those in the relatively poorly characterized RBR
and HECT families, and how these mechanisms are altered
in human diseases. For instance, the HECT ligase HUWE1
has both pro-oncogenic and tumor suppressor functions,
depending on the cellular context (Zhao et al., 2008; Inoue et al.,
2013; Peter et al., 2014; King et al., 2016; Myant et al., 2017).
Which macromolecular complexes mediate these functions by
mediating substrate selection, activity, and linkage specificity
of this crucial ligase remains to be determined. It will also
be important to identify the consequences of patient-derived
mutations in disease-associated ligase genes in order to develop
efficient strategies targeting these enzymes therapeutically.
Finally, a better understanding of the mechanisms of ubiquitin
chain formation will facilitate the development of bifunctional
small molecules, known as PROTACs (Sakamoto et al., 2002),
that re-program a particular ligase to mark a pathogenic target
protein for degradation – a powerful concept that has recently
entered clinical trials (Mullard, 2019).
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